Skip to content

UrjansMed

Active Private limited companyfounded 2024active for 2 yearsRue du Fays 32, 4450 JuprelleKBO/BCE: BE 1010.015.369

Lifetime

2 annual accounts with figures on one time axis
peak of €88,200 in 2025
€88,200▲ 317%
peak of €68,208 in 2025
€68,208▲ 377%
peak of €81,636 in 2025
€81,636▲ 401%
€25,641▲ 212%
Board1 name since 2024
1 director
Documentsfilings and deeds
06-07-202625 days before the deadline
2025micro format
Gross margin from €21,160 to €88,200Result from €14,285 to €68,208Dividend €2,857Equity from €16,285 to €81,636Debts from €8,224 to €25,641Cash from €6,742 to €86,986

Key points

from the 2025 annual accounts

Equity

€81,636 ▲ 401%
16,2852024+68,208Profit-2,857Dividend81,6362025

UrjansMed paid out €2,857 in dividends. That is 4% of the 2025 profit.

Result

€68,208 ▲ 377%
€14,3002024€68,2002025

The result rose in 2025 from €14,285 to €68,208.

Turnover

≈ €260,000 estimated

The micro format states no turnover.

Investments

€2,777 9.1 times depreciation

Green is investment, beige is depreciation.

Liquidity

4.09 was 2.98 in 2024

Short-term debts rose from €8,224 to €25,641.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as UrjansMed has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for UrjansMed. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 04-06-2024
  • 100 sharesdeed of 06-06-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1010015369
First establishment Rue du Fays 32, Juprelle
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 06-06-2024 · Gazette deed
All 5 events

Official details

Source: KBO
Status
Active since 04-06-2024Normal situation
Activity
General medical practiceNACE 86210and 1 other2 activities on the establishment unitFrom the articles
Establishment unit
2.363.051.9394450 Juprelle, since 07-10-2024
Financial year end
31 December
Peppol
Reachable since 30-03-2026
Company details

Annual accounts 2025

€107,277▲ 338%
Filing
Filed on 06-07-2026, 25 days before the end of the filing period
Financials

Insights on UrjansMed

UrjansMed has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €81,636 and a net result of €68,208.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about UrjansMed

What is the company number of UrjansMed?
The company number of UrjansMed is 1010.015.369. The VAT number is the same number with BE in front: BE 1010.015.369.
Where is UrjansMed based?
The registered office is at Rue du Fays 32, 4450 Juprelle.Company details
What does UrjansMed do?
According to the KBO register, the main activity of the establishment unit is general medical practice (NACE 86210). The KBO lists 1 more.
What is the legal form of UrjansMed?
UrjansMed is a private limited company (BV).
When was UrjansMed founded?
UrjansMed was founded on 04-06-2024.
Is UrjansMed still active?
Yes, UrjansMed is an active enterprise in the KBO register.
What is the turnover of UrjansMed?
The turnover in financial year 2025 is about €260,000. This figure is estimated from the gross margin of €88,200 and 2,990 comparable companies of the same size. It probably lies between €170,000 and €460,000. It is a rough estimate.Financials
Is UrjansMed profitable?
In financial year 2025, UrjansMed made a profit of €68,208.
Where can I find the annual accounts of UrjansMed?
UrjansMed filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of UrjansMed due?
UrjansMed must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.